Bank of America’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-532,600
Closed -$52M 7440
2025
Q3
$52M Buy
532,600
+237,200
+80% +$24.6M ﹤0.01% 1730
2025
Q2
$31.7M Sell
295,400
-584,300
-66% -$59.1M ﹤0.01% 2094
2025
Q1
$88.7M Sell
879,700
-268,300
-23% -$27M 0.01% 1158
2024
Q4
$103M Sell
1,148,000
-25,000
-2% -$2.2M 0.01% 1004
2024
Q3
$98.3M Buy
1,173,000
+58,000
+5% +$4.57M 0.01% 1078
2024
Q2
$85.9M Buy
1,115,000
+292,300
+36% +$21.4M 0.01% 1101
2024
Q1
$56.3M Buy
822,700
+74,900
+10% +$4.82M 0.01% 1397
2023
Q4
$43.2M Buy
747,800
+20,000
+3% +$1.07M ﹤0.01% 1476
2023
Q3
$38.4M Buy
727,800
+175,200
+32% +$9.19M ﹤0.01% 1459
2023
Q2
$29.9M Buy
552,600
+203,200
+58% +$10.6M ﹤0.01% 1674
2023
Q1
$17.5M Buy
349,400
+189,700
+119% +$8.94M ﹤0.01% 2252
2022
Q4
$7.39M Buy
159,700
+72,500
+83% +$3.14M ﹤0.01% 2983
2022
Q3
$3.38M Buy
87,200
+76,500
+715% +$3.07M ﹤0.01% 3764
2022
Q2
$399K Sell
10,700
-57,100
-84% -$2.32M ﹤0.01% 5589
2022
Q1
$3M Sell
67,800
-79,300
-54% -$3.44M ﹤0.01% 4172
2021
Q4
$6.25M Sell
147,100
-145,700
-50% -$6.12M ﹤0.01% 3423
2021
Q3
$12.7M Sell
292,800
-209,300
-42% -$9.26M ﹤0.01% 2594
2021
Q2
$21.5M Buy
502,100
+387,700
+339% +$16.3M ﹤0.01% 2079
2021
Q1
$4.42M Sell
114,400
-8,600
-7% -$325K ﹤0.01% 3520
2020
Q4
$4.42M Buy
123,000
+111,100
+934% +$4M ﹤0.01% 3246
2020
Q3
$455K Hold
11,900
﹤0.01% 4782
2020
Q2
$418K Hold
11,900
﹤0.01% 4740
2020
Q1
$388K Sell
11,900
-416,400
-97% -$16.3M ﹤0.01% 4684
2019
Q4
$19.4M Buy
428,300
+268,300
+168% +$11.2M ﹤0.01% 1911
2019
Q3
$6.51M Sell
160,000
-2,100
-1% -$89K ﹤0.01% 2948
2019
Q2
$6.97M Buy
162,100
+140,800
+661% +$5.42M ﹤0.01% 2906
2019
Q1
$818K Sell
21,300
-171,600
-89% -$6.55M ﹤0.01% 4672
2018
Q4
$6.82M Buy
192,900
+192,800
+192,800% +$6.99M ﹤0.01% 2676
2018
Q3
$4K Sell
100
-50,000
-100% -$1.75M ﹤0.01% 6863
2018
Q2
$1.64M Buy
50,100
+50,000
+50,000% +$1.51M ﹤0.01% 4124
2018
Q1
$3K Hold
100
﹤0.01% 6840
2017
Q4
$2K Hold
100
﹤0.01% 6849
2017
Q3
$3K Buy
+100
New +$2.76K ﹤0.01% 6808
2016
Q2
Sell
-43,700
Closed -$822K 7126
2016
Q1
$822K Buy
+43,700
New +$768K ﹤0.01% 4243
2015
Q3
Sell
-120,000
Closed -$2.12M 7210
2015
Q2
$2.12M Buy
+120,000
New +$2.14M ﹤0.01% 3403
2015
Q1
Sell
-3,100
Closed -$41K 7074
2014
Q4
$41K Sell
3,100
-5,000
-62% -$63.9K ﹤0.01% 6448
2014
Q3
$96K Buy
8,100
+3,900
+93% +$49.1K ﹤0.01% 6036
2014
Q2
$54K Buy
4,200
+2,700
+180% +$35.1K ﹤0.01% 6597
2014
Q1
$20K Sell
1,500
-14,800
-91% -$194K ﹤0.01% 6906
2013
Q4
$196K Buy
16,300
+1,200
+8% +$14.2K ﹤0.01% 5612
2013
Q3
$177K Sell
15,100
-16,900
-53% -$183K ﹤0.01% 5549
2013
Q2
$297K Buy
+32,000
New +$271K ﹤0.01% 5243

Other funds holding BSX

Bank of America's BSX Position: Q1 2026 in Review

Bank of America reduced its Boston Scientific (BSX) stake by 9.4% in Q1 2026, selling an estimated $189M and leaving 22,756,646 shares worth $1.43B. The position accounts for 0.1% of the portfolio, ranked #187.

Bank of America first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64B in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bank of America held 22,756,646 shares of Boston Scientific worth $1.43B as of Q1 2026.
  • Bank of America sold 2,358,539 Boston Scientific shares in Q1 2026, an estimated $189M.
  • Boston Scientific made up 0.1% of Bank of America's portfolio in Q1 2026, its #187 holding.
  • Bank of America first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Boston Scientific position peaked at $3.64B in Q2 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.